Kwality Pharmaceuticals has received approval from BSE Limited vide letter reference no LOMigrationSCMIG-TP862022-23 dated June 10 2022 wherein BSE has approved the Companys application with respect to migration of equity shares of the company from BSE SME platform to BSE Main Board Platform wef 13 June 2022 and the Company will be categorized under the list of B Group Category
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
